Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

GH

Live52w high -21.4%

Annual Quarterly

Core line items from GH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Annual Quarterly

Entity: GUARDANT HEALTH, INC.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-07-28	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$320.29M	$301.67M	$982.02M	$700.75M	$435.56M
Operating Income	Not available	$-121.35M	$-437.25M	$-316.44M	$-217.45M
Net Income	Not available	$-112.08M	$-416.28M	$-287.78M	$-195.06M
EPS (Diluted)	$-0.61	$-0.85	$-3.32	$-2.32	$-1.57
Total Assets	Not available	$1.92B	$2.01B	$1.28B	$1.33B
Total Liabilities	Not available	$2.10B	$2.11B	$1.63B	$1.64B
Cash & Equivalents	Not available	$989.29M	$378.20M	$580.01M	$629.14M
Free Cash Flow OCF − CapEx	Not available	$-71.20M	$-233.07M	$-178.84M	$-133.08M
Shares Outstanding	Not available	131.51M	130.64M	125.01M	124.48M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.

Core line items from GH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w high -21.4%

Entity: GUARDANT HEALTH, INC.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-07-28	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$320.29M	$301.67M	$982.02M	$700.75M	$435.56M
Operating Income	Not available	$-121.35M	$-437.25M	$-316.44M	$-217.45M
Net Income	Not available	$-112.08M	$-416.28M	$-287.78M	$-195.06M
EPS (Diluted)	$-0.61	$-0.85	$-3.32	$-2.32	$-1.57
Total Assets	Not available	$1.92B	$2.01B	$1.28B	$1.33B
Total Liabilities	Not available	$2.10B	$2.11B	$1.63B	$1.64B
Cash & Equivalents	Not available	$989.29M	$378.20M	$580.01M	$629.14M
Free Cash Flow OCF − CapEx	Not available	$-71.20M	$-233.07M	$-178.84M	$-133.08M
Shares Outstanding	Not available	131.51M	130.64M	125.01M	124.48M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.